These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5664936)

  • 21. An economic appraisal of a mobile cervical cytology screening service.
    Bloch B
    S Afr Med J; 1997 Feb; 87(2):231. PubMed ID: 9180819
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of cervical cancer screening for prevention of carcinoma cervix.
    Christe DM; Mohanambal M; Ramamurthy V; Snehaa NB
    J Indian Med Assoc; 2008 Dec; 106(12):779-80, 782. PubMed ID: 19370947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-wavelength Feulgen cytophotometry of cells exfoliated from the uterine cervix.
    Hrushovetz SB
    Acta Cytol; 1969 Oct; 13(10):583-94. PubMed ID: 4186897
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytologic screening for cervical cancer in southern Iran.
    Behmard S; Taherzadeh D; Gondos B
    Acta Cytol; 1977; 21(3):432-4. PubMed ID: 268125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quality of cervical cytological tests without endocervical cells].
    Nielsen K
    Ugeskr Laeger; 2004 Sep; 166(38):3313. PubMed ID: 15496012
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphoid cells in the uterine cervix after electrocoagulation.
    Bukovský A; Trebichavský I; Presl J
    J Reprod Med; 1979 Jul; 23(1):42-5. PubMed ID: 490491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytologic and histologic studies of the portio and cervix uteri during administration of ovulation inhibitors. Preliminary report].
    Dallenbach-Hellweg G; Herting W; Momber F; Thorn V
    Fortschr Med; 1971 Aug; 89(22):883-7. PubMed ID: 5154176
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Screening for prevention of cervical cancer in the Czech Republic].
    Tachezy R; Rob L
    Cas Lek Cesk; 2007; 146(12):939-44. PubMed ID: 18257411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differential diagnosis of uterine cervical and endometrial cells and oviductal epithelial cells in women].
    Wawryk R; Dudkiewicz J; Tomala J
    Patol Pol; 1972; 23(3):299-307. PubMed ID: 5072521
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vascular tracings of the cervix uteri in the colpomicroscopic picture].
    Kopecný J
    Zentralbl Gynakol; 1967 Sep; 89(36):1324-8. PubMed ID: 5593156
    [No Abstract]   [Full Text] [Related]  

  • 34. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening.
    Jones HE; Wiegerinck MA; Nieboer TE; Mol BW; Westhoff CL
    Sex Transm Dis; 2008 Nov; 35(11):916-7. PubMed ID: 18665020
    [No Abstract]   [Full Text] [Related]  

  • 36. [Screening for cervical cancer in East Germany--a progress report].
    Ebeling K; Nischan P
    Z Arztl Fortbild (Jena); 1986; 80(7):278-305. PubMed ID: 3487887
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrasonic dispersal of cervical cell aggregates.
    Parry JS; Cleary BK; Williams AR; Evans DM
    Acta Cytol; 1971; 15(2):163-6. PubMed ID: 5282947
    [No Abstract]   [Full Text] [Related]  

  • 38. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomechanical clues from morphologically normal cervical squamous cells could improve cervical cancer screening.
    Geng L; Feng J; Sun Q; Liu J; Hua W; Li J; Ao Z; You K; Guo Y; Liao F; Zhang Y; Guo H; Han J; Xiong G; Zhang L; Han D
    Nanoscale; 2015 Oct; 7(38):15589-93. PubMed ID: 26370304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Flow-through cytophotometric prescreening--a comparison of methods (author's transl)].
    Sprenger E; Schaden M; Wagner D; Hilgarth M; Sandritter W
    Beitr Pathol; 1974 Apr; 151(4):373-83. PubMed ID: 4135140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.